COMPANY OVERVIEW

Synspira Therapeutics is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis and other rare diseases where there is a high unmet treatment need.

---

LOCATION

Framingham, MA, USA

---

THERAPEUTIC AREAS

Rare Diseases

Respiratory Disease

---

WEBSITE

https://www.synspira.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Oct 20, 2020

Synspira Therapeutics Announces Expanded Agreement with Cystic Fibrosis Foundation to Advance Promising Treatments for Cystic Fibrosis

Oct 20, 2020

CF Foundation Commits up to $14 Million in Funding to Expand Research Agreement With Synspira Therapeutics

Feb 12, 2020

Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes

Oct 28, 2019

Synspira Therapeutics Appoints Industry Leaders Dr. Alexey Margolin And Robert K. Coughlin To Board Of Directors

Apr 10, 2019

Synspira Therapeutics Receives Orphan Designation for SNSP113 for the Treatment of Cystic Fibrosis in the European Union

For More Press Releases

---